A new trading day began on Friday, with Sangamo Therapeutics Inc (NASDAQ: SGMO) stock price down -4.46% from the previous day of trading, before settling in for the closing price of $1.12. SGMO’s price has ranged from $0.30 to $3.18 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 16.98% over the past five years. Meanwhile, its annual earnings per share averaged 68.41%. With a float of $200.01 million, this company’s outstanding shares have now reached $208.62 million.
Let’s look at the performance matrix of the company that is accounted for 405 employees. In terms of profitability, gross margin is 84.55%, operating margin of -256.63%, and the pretax margin is -257.89%.
Sangamo Therapeutics Inc (SGMO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Sangamo Therapeutics Inc is 4.14%, while institutional ownership is 29.74%.
Sangamo Therapeutics Inc (SGMO) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 68.41% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 42.22% during the next five years compared to -15.96% drop over the previous five years of trading.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Trading Performance Indicators
Here are Sangamo Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.74, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.27 in one year’s time.
Technical Analysis of Sangamo Therapeutics Inc (SGMO)
Sangamo Therapeutics Inc (NASDAQ: SGMO) saw its 5-day average volume 3.3 million, a negative change from its year-to-date volume of 4.99 million. As of the previous 9 days, the stock’s Stochastic %D was 14.15%. Additionally, its Average True Range was 0.12.
During the past 100 days, Sangamo Therapeutics Inc’s (SGMO) raw stochastic average was set at 13.40%, which indicates a significant increase from 5.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.17% in the past 14 days, which was lower than the 185.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5118, while its 200-day Moving Average is $1.1207. Nevertheless, the first resistance level for the watch stands at $1.1400 in the near term. At $1.2100, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.2550. If the price goes on to break the first support level at $1.0250, it is likely to go to the next support level at $0.9800. The third support level lies at $0.9100 if the price breaches the second support level.
Sangamo Therapeutics Inc (NASDAQ: SGMO) Key Stats
With a market capitalization of 223.25 million, the company has a total of 208,647K Shares Outstanding. Currently, annual sales are 176,230 K while annual income is -257,830 K. The company’s previous quarter sales were 49,410 K while its latest quarter income was 10,670 K.
